TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive DCE Board Approves New Study to Seek Causes Of Rising Breast Cancer Incidence In Young Women May 27, 1988
TCL Archive Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials September 8, 1978
TCL Archive In Brief : Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center June 20, 2014